Stephen K. Brannan, Chief Medical Officer at Karuna Therapeutics, Inc. (KRTX), sold 9,940 shares at $183.07 ($1.8M) on 2023-09-08, disclosed to the SEC on 2023-09-11.
Scheduled sale ($1.8M) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $183.07 | 1,276 | $234K | 12.8% |
| 2 | $183.07 | 1,276 | $234K | 12.8% |
| 3 | $184.13 | 2,756 | $507K | 27.7% |
| 4 | $184.13 | 2,756 | $507K | 27.7% |
| 5 | $185.03 | 908 | $168K | 9.2% |
| 6 | $185.03 | 908 |
| $168K |
| 9.2% |
| 7 | $185.60 | 60 | $11K | 0.6% |
| Total | $184.03 avg | 9,940 | $1.8M | 100% |
| Filing → |
| KRTX | SELL | 2024-02-12 | $3.2M | — | Filing → |
| KRTX | SELL | 2024-01-09 | $4.8M | — | Filing → |
| KRTX | SELL | 2023-12-12 | $4.0M | — | Filing → |